Medplus Health

34
Sell
  • Market Cap: Small Cap
  • Industry: Retailing
  • ISIN: INE804L01022
  • NSEID: MEDPLUS
  • BSEID: 543427
INR
806.90
-6.55 (-0.81%)
BSENSE

Dec 05

BSE+NSE Vol: 92.83 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
6,136.00
5,624.00
4,557.00
3,779.00
3,069.00
2,870.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
6,136.00
5,624.00
4,557.00
3,779.00
3,069.00
2,870.00
Expenditure (Ex Depriciation)
Stock Adjustments
6.00
-190.00
-221.00
-159.00
-105.00
-247.00
Raw Materials Consumed
4,634.00
4,582.00
3,778.00
3,141.00
2,530.00
2,584.00
Power & Fuel Cost
52.00
45.00
31.00
17.00
13.00
13.00
Employee Cost
726.00
625.00
545.00
393.00
338.00
272.00
Operating Expenses
100.00
82.00
65.00
44.00
28.00
32.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
43.00
51.00
35.00
30.00
19.00
23.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
7.00
6.00
5.00
4.00
1.00
37.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
5,648.00
5,270.00
4,291.00
3,506.00
2,852.00
2,736.00
Operating Profit (PBDIT) excl Other Income
487.00
354.00
265.00
272.00
216.00
133.00
Other Income
48.00
40.00
46.00
31.00
21.00
17.00
Operating Profit (PBDIT)
535.00
394.00
311.00
303.00
238.00
150.00
Interest
102.00
96.00
83.00
66.00
54.00
46.00
Profit before Depriciation and Tax
433.00
297.00
228.00
237.00
183.00
104.00
Depreciation
249.00
224.00
181.00
119.00
88.00
74.00
Profit Before Taxation & Exceptional Items
183.00
73.00
47.00
117.00
95.00
29.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
183.00
73.00
47.00
117.00
95.00
29.00
Provision for Tax
33.00
7.00
-2.00
23.00
31.00
27.00
Profit After Tax
150.00
65.00
50.00
94.00
63.00
1.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
279.00
213.00
163.00
66.00
1.00
1.00
Profit Available for appropriations
429.00
279.00
213.00
161.00
65.00
4.00
Appropriations
429.00
279.00
213.00
161.00
65.00
4.00
Equity Dividend (%)
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Earnings Per Share
12.57
5.48
4.17
8.55
6.13
1.05
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 9.09% vs 23.42% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 37.57% vs 33.28% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 6.38% vs 16.15% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 129.09% vs 30.88% in Mar 2024

Compare Profit and Loss Results of Medplus Health
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
6,136.00
7,829.00
-1,693.00
-21.62%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
6,136.00
7,829.00
-1,693.00
-21.62%
Expenditure (Ex Depriciation)
Stock Adjustments
6.00
140.00
-134.00
-95.71%
Raw Materials Consumed
4,634.00
3,131.00
1,503.00
48.00%
Power & Fuel Cost
52.00
88.00
-36.00
-40.91%
Employee Cost
726.00
918.00
-192.00
-20.92%
Operating Expenses
100.00
681.00
-581.00
-85.32%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
43.00
472.00
-429.00
-90.89%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
7.00
61.00
-54.00
-88.52%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
5,648.00
6,606.00
-958.00
-14.50%
Operating Profit (PBDIT) excl Other Income
487.00
1,223.00
-736.00
-60.18%
Other Income
48.00
77.00
-29.00
-37.66%
Operating Profit (PBDIT)
535.00
1,300.00
-765.00
-58.85%
Interest
102.00
413.00
-311.00
-75.30%
Profit before Depriciation and Tax
433.00
887.00
-454.00
-51.18%
Depreciation
249.00
705.00
-456.00
-64.68%
Profit Before Taxation & Exceptional Items
183.00
181.00
2.00
1.10%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
183.00
83.00
100.00
120.48%
Provision for Tax
33.00
23.00
10.00
43.48%
Profit After Tax
150.00
59.00
91.00
154.24%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
279.00
0.00
279.00
0%
Profit Available for appropriations
429.00
59.00
370.00
627.12%
Appropriations
429.00
59.00
370.00
627.12%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
12.57
0.49
12.08
2,465.31%
Profit And Loss - Net Sales
Net Sales 6,136.05 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 9.09% vs 23.42% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 487.10 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 37.57% vs 33.28% in Mar 2024

Profit And Loss - Interest
Interest 102.59 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 6.38% vs 16.15% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 150.23 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 129.09% vs 30.88% in Mar 2024